Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-10-22
1999-07-27
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5462684, 5462724, 548217, 5483047, 548466, 549462, A61K 3144, C07D40514
Patent
active
059290943
ABSTRACT:
The present invention is directed to certain novel compounds represented by structural formula I: ##STR1## or a pharmaceutically acceptable salt thereof, wherein R.sup.3, R.sup.6, R.sup.7, R.sup.8, R.sup.11, R.sup.12, R.sup.13, A, m, n and the dashed lines are defined herein. The invention is also concerned with pharmaceutical formulations comprising these novel compounds as active ingredients and the use of the novel compounds and their formulations in the treatment of certain disorders. The compounds of this invention are tachykinin receptor antagonists and are useful in the treatment of inflammatory diseases, pain or migraine, asthma and emesis.
REFERENCES:
patent: 5300524 (1994-04-01), Davidson et al.
patent: 5387595 (1995-02-01), Mills et al.
patent: 5688806 (1997-11-01), Desai et al.
Durette Philippe
Kopka Ihor
Maccoss Malcolm
Mills Sander
Aulakh Charanjit S.
Merck & Co. , Inc.
Rose David L.
Rotman Alan L.
Thies J. Eric
LandOfFree
Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-879085